Senate Passes Science Bond
SB 895 includes groundbreaking requirements to make health care more affordable for Californians and ensure profitable discoveries reinvest some funds back in California. The measure does so in three main ways:
- Makes pharmaceuticals developed through this research available to Californians at a discount;
- Allows the state to recoup a portion of licensing and royalty fees from inventions and technologies produced as a result of bond-funded research; and
- Allows California to publicly produce pharmaceuticals invented with bond-funded research via CalRx in order to sell them at cost to Californians
